Cancer Research The Future of Cancer Research: Science and Patient Impact  AACR Conference on Molecular Diagnostics - 2008
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online

[Cancer Research 49, 3737-3741, July 15, 1989]
© 1989 American Association for Cancer Research

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Ahir, S.
Right arrow Articles by Mohla, S.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Ahir, S.
Right arrow Articles by Mohla, S.

Regulation of Renal N-Nitrosodimethylamine Demethylase Activity by Androgens, Progestin, Glucocorticoid, and Estrogen in BALB/c Mice1

Surender Ahir and Suresh Mohla2

Howard University Cancer Center and the Departments of Oncology [S. A., S. M.] and Genetics and Human Genetics [S. M.], Howard University, Washington, DC 20060

Studies from this laboratory have shown that renal N-nitrosodimethylamine demethylase (NDMA demethylase), an enzyme responsible for the metabolism of NDMA, shows age- and sex-related differences and is modulated by testosterone. These results have been positively correlated with NDMA-induced mutagenicity and carcinogenicity studies; however, relatively large doses of testosterone (100 mg/kg or 2 mg/day) had been used. The objective of this study was to determine whether this tissue specific increase in renal NDMA demethylase was evident only with pharmacological doses or could be observed at lower doses of testosterone, and, to determine whether this testosterone-induced increase in renal NDMA demethylase was specific for androgenic hormones.

BALB/c mice were given injections s.c. of varying doses of testosterone (0.01 to 1.5 mg/day) in 0.1 ml of peanut oil for 1, 4, 8, or 16 days; control mice received peanut oil alone. A 3-fold increase in renal NDMA demethylase was observed within 24 h with 0.01 mg of testosterone. Dosedependent increases of 3-, 5-, and 11-fold were observed at 0.01, 0.05, and 0.10 mg of testosterone, respectively. Hepatic NDMA demethylase was not affected.

To determine whether this induction was specific for androgenic hormones, several hormones (androgens, estrogen, glucocorticoid, and progestin) were used. A 5-, 7-, and 2-fold stimulation of renal NDMA demethylase activity was observed in female mice with 5{alpha}-dihydrotestosterone, synthetic androgen methyltrienolone, and androgen agonist medroxyprogesterone acetate, respectively. The biologically inactive 5ß-dihydrotestosterone, stereomer of 5{alpha}-dihydrotestosterone, had no effect. Medroxyprogesterone, methyltrienolone, testosterone, and 5{alpha}-dihydrotestosterone exert their effect by interacting with androgen receptors; 5ß-dihydrotestosterone does not bind to androgen receptors. Dexamethasone or estradiol treatment resulted in a significant inhibition of renal enzyme activity in male mice. None of the treatments affected hepatic NDMA demethylase activities in male or female mice. This rapid and tissue specific stimulation of renal NDMA demethylase with low doses of testosterone or with other androgen agonists seems to be androgen receptor mediated and indicates a physiological relevance of this phenomenon.

1 Supported by Grant R810451-01 from the United States Environmental Protection Agency and Grant P30-CA-147186 from the National Cancer Institute.

2 To whom requests for reprints should be addressed, at Department of Oncology, Howard University Cancer Center, 2041 Georgia Avenue, N.W., Washington, DC 20060.

Received 10/25/88. Revised 3/27/89. Accepted 4/12/89.







HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online
Copyright © 1989 by the American Association for Cancer Research.